RT
The primary objective was to determine the safety, tolerability and maximum tolerated dose (MTD) of V. We used multianalyte biomarker profiling (Luminex Corp) and ELISA to assess 57 plasma markers before and after 14 d of V and at completion of RT (d50), and EGFR, p16, E-cadherin and vimentin immunohistochemistry in tumor tissue.